Provided by Tiger Trade Technology Pte. Ltd.

OmniAb, Inc.

4.38
+0.05321.23%
Volume:373.28K
Turnover:1.62M
Market Cap:634.61M
PE:-12.37
High:4.44
Open:4.35
Low:4.20
Close:4.33
52wk High:4.59
52wk Low:1.30
Shares:144.78M
Float Shares:107.31M
Volume Ratio:0.22
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3543
EPS(LYR):-0.5701
ROE:-16.95%
ROA:-8.35%
PB:2.44
PE(LYR):-7.69

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Aug 18

Top Midday Gainers

MT Newswires Live
·
Aug 18

OmniAb Price Target Maintained with a $11.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 18

U.S. Stocks on the MOVE - Sunrun, JetBlue Airways, Dell Technologies

Reuters
·
Aug 17

Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)

TIPRANKS
·
Aug 17

H.C. Wainwright Keeps Their Buy Rating on OmniAb (OABI)

TIPRANKS
·
Aug 17

Nasdaq Opens Slightly Higher; Memory‑Related Stocks Broadly Higher, SanDisk up over 5%, SK Hynix up 4%; OABI Surges 19%

Tiger Newspress
·
Aug 17

U.S. Stocks on the MOVE - KBR, Vista Energy, Fulcrum Therapeutics

Reuters
·
Aug 17

Top Premarket Gainers

MT Newswires Live
·
Aug 17

Shares OmniAb Jump 36.3% Premarket on $370 Mln Drug Discovery Deal with Eli Lilly

THOMSON REUTERS
·
Aug 17

OmniAb Enters $370‑Million Drug‑Development Deal With Eli Lilly

Reuters
·
Aug 17

OmniAb Lifts 2026 Year-End Cash Outlook to $49 Million-$53 Million

Reuters
·
Aug 17

OmniAb Raises 2026 Financial Guidance

THOMSON REUTERS
·
Aug 17

OmniAb - Expects 2026 Year-End Cash and Cash Equivalents of $49 Mln-$53 Mln

THOMSON REUTERS
·
Aug 17

OmniAb Signs Global Ion Channel Collaboration Deal with Eli Lilly, Eyes up to $370 Million in Milestones

Reuters
·
Aug 17

OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company

THOMSON REUTERS
·
Aug 17

OmniAb - to Receive Upfront Payment and up to $370 Mln in Milestone Payments Plus Royalties

THOMSON REUTERS
·
Aug 17

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), OmniAb (OABI) and Astrana Health (ASTH)

TIPRANKS
·
Aug 07

OmniAb Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

OmniAb Q2 Revenue Beats Analyst Estimates, Outlook Raised

Reuters
·
Aug 07